2023-09-18 22:00:36
Germany at risk of missing World Health Organization’s goals for eliminating viral hepatitis by 2030
The World Health Organization (WHO) has set a goal to eliminate viral hepatitis as a threat to public health by 2030. This includes reducing the rate of new infections by 80 percent and the mortality rate resulting from an infection by 65 percent. However, experts are warning that Germany may be in danger of missing these targets.
The situation in Germany is concerning, with the necessary measures and actions not being implemented effectively. Without significant progress, the country may not be able to achieve the WHO’s goals within the given timeframe.
To address this issue, experts are calling for increased efforts and investments in prevention, testing, treatment, and public awareness campaigns. These interventions are crucial in order to reduce the number of new infections and deaths caused by viral hepatitis.
It is important for policymakers, healthcare professionals, and the general public to recognize the urgency of the situation and take proactive steps to combat viral hepatitis. This includes improving access to testing and treatment, implementing vaccination programs, and raising awareness about the disease and its prevention methods.
The consequences of not meeting the WHO’s goals for eliminating viral hepatitis are significant. Without progress, the burden of the disease will continue to impact individuals, families, and communities, including the healthcare system and the economy as a whole.
Germany must prioritize the fight against viral hepatitis and work towards achieving the WHO’s goals. By doing so, the country can protect the health and well-being of its population and contribute to global efforts to eliminate this public health threat.
To read more about this topic and stay updated on Lower Saxony’s state politics and economy, a Rundblick subscription is required. Subscribers will gain access to exclusive stories and in-depth coverage. There are different subscription options available, including a free two-week trial, individual subscriptions for €37 per month or €111 per quarter, and collective subscriptions for authorities and companies (price on request).
It is crucial to stay informed and take action in order to address the challenges posed by viral hepatitis and work towards its elimination.]
#prisoners #syringes #condoms #stop #hepatitis #Panoramic #view #Saxony